M Bio Technology

M Bio Technology Inc.

基本情報

場所(HQ)

Tokyo, JP

その他の場所

Chiba, JP

からのスピンアウト

Webサイト

最高経営責任者(CEO

に設立されました 

Kazuhiro Matsuda

2005

事業内容

M Biotech has key patents for the structure of glycolipid on mycoplasma membrane surfaces as well as its synthesis methodology. These technologies could be applied both for high sensitive diagnoses and vaccine development with applying the glycolipid-antigen to produce its antibody. M Biotech encourages global business expansion with identifying the business and technical partners.

ビジネス分野

キーワード

Mycoplasma

Glycolipid

Antigen

Vaccine

TRL

5

主要な文献

Synthesis and absolute structures of Mycoplasma pneumoniae β-glyceroglycolipid antigens

Chemosynthetic homologues of Mycoplasma pneumoniae β-glycolipid antigens for the diagnosis of mycoplasma infectious diseases

Detection of serum antibodies against phosphocholine-containing aminoglycoglycerolipid specific to Mycoplasma fermentans in HIV-1 infected individuals

会社の価値観

出願された特許の数

2

特許ID

Please ask

総特許額(USD)

Over $3m

ビジネスステージ

Series B stage / global alliance

要求されたコラボレーションの種類

R&D Collaboration, Oversea business partners

理想的な出口モデル

Licensing out

序章

M Biotech has key patents related to the structure of glycolipid on mycoplasma membrane surfaces as well as its synthesis methodology. These technologies can be applied to highly sensitive diagnoses and vaccine development using the glycolipid-antigen to produce its antibody. M Biotech is en-route to global business expansion by collaborating with business and technical partners.

ライセンス供与の機会

Licensing is also available especially in the field of vaccine development. Please ask for details.

投資機会